Synedica Retatrutide 40mg
Synedica Retatrutide 40mg is an analytical-grade research peptide developed for advanced metabolic and endocrine studies. As a triple hormone receptor agonist targeting GCGR, GIPR, and GLP-1R, Retatrutide offers researchers a robust tool for evaluating multi-pathway signaling mechanisms.
Product Specifications & Purity Profile
| Parameter | Specification |
| Product Name | Synedica Retatrutide |
| Concentration / Mass | 40mg per vial |
| Form | Lyophilized powder |
| Purity Grade | $\ge 98\%$ (HPLC Verified) |
| Storage Conditions | Store at $-20^\circ\text{C}$; protect from moisture and light |
| Application | In Vitro Laboratory Research |
Research Applications & Properties of Synedica Retatrutide 40mg
Multi-Receptor Agonism in Biochemical Research
Retatrutide continues to be a central focus in energy balance and metabolic pathway investigations. Researchers investigating receptor activation profiles utilize Synedica Retatrutide 40mg to study:
-
Triple-receptor synergy across glucagon, GIP, and GLP-1 pathways.
-
Receptor binding affinity and signaling kinetics in cellular assays.
-
Comparative efficiency against single and dual agonist controls.
Reconstitution and Storage Recommendations
To ensure long-term stability and prevent degradation of the peptide sequence, reconstitute using sterile bacteriostatic water under a laminar flow hood. Aliquot into single-use portions to prevent repeated freeze-thaw cycles.
Related Research Compounds
Enhance your comparative study models by exploring our complete catalog of metabolic research peptides:
-
Compare multi-receptor mechanisms with Synedica Tirzepatide 40mg.
-
Return to the Synedica Research Lab Homepage to view new arrivals and updates.